14 results on '"Bouchaab, H."'
Search Results
2. Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy
3. Lung stereotactic radiation therapy: Intercomparison of irradiation devices in terms of outcome and predictive factors
4. Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
5. A PET-based nomogram for oropharyngeal cancers
6. Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis.
7. P2.12-21 Outcomes with Immune Checkpoint Inhibitors (ICI) for Relapsed Small Cell Lung Cancer (SCLC) in a Swiss Cohort.
8. MA05.01 Second or Third Line Anti-PD-1 Therapy After Multimodality Therapy Including Total Pleurectomy in Malignant Pleural Mesothelioma.
9. Definitive organ-sparing treatment of anal canal cancer: can we afford to question it?
10. Helical Intensity Modulated Radiation Therapy With Daily Image Guidance in the Treatment of Anal Canal Cancer.
11. 1047P Tocilizumab is an effective secondary prophylaxis during immune checkpoint inhibitor rechallenge following arthritis.
12. PV-0518: Phase 1 study of Debio 1143 in combination with Concurrent Chemo-Radiotherapy in LA-SCCHN.
13. Carotid Dose Sparing in Definitive Irradiation of Early-Stage Glottic Cancer Using Helical Tomotherapy–Based Image-Guided Intensity Modulated Radiation Therapy.
14. 1242P Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.